2017
DOI: 10.20546/ijcmas.2017.604.115
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis of Bacterial Vaginosis among Symptomatic Egyptian Women: Value of Assessing Bacterial Sialidase Activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 31 publications
0
2
0
Order By: Relevance
“…In studies of predominately symptomatic women in the United States, Canada, Australia, Malaysia, Egypt, and India, the BVBlue test's sensitivity (range, 88%–100%) and specificity (range, 85%–99%) were high compared with BV by Nugent score 11–15 . However, the test performed poorly in one study in the United States including asymptomatic and symptomatic women, in symptomatic women in sub-Saharan Africa (Uganda, Zimbabwe, South Africa), and in Indian women with vaginal pH >4.5; sensitivity ranged from 38% to 61% 16–18 .…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…In studies of predominately symptomatic women in the United States, Canada, Australia, Malaysia, Egypt, and India, the BVBlue test's sensitivity (range, 88%–100%) and specificity (range, 85%–99%) were high compared with BV by Nugent score 11–15 . However, the test performed poorly in one study in the United States including asymptomatic and symptomatic women, in symptomatic women in sub-Saharan Africa (Uganda, Zimbabwe, South Africa), and in Indian women with vaginal pH >4.5; sensitivity ranged from 38% to 61% 16–18 .…”
Section: Discussionmentioning
confidence: 97%
“…In studies of predominately symptomatic women in the United States, Canada, Australia, Malaysia, Egypt, and India, the BVBlue test's sensitivity (range, 88%-100%) and specificity (range, 85%-99%) were high compared with BV by Nugent score. [11][12][13][14][15] However, the test performed poorly in one study in the United States including asymptomatic and symptomatic women, in symptomatic women in sub-Saharan Africa (Uganda, Zimbabwe, South Africa), and in Indian women with vaginal pH >4.5; sensitivity ranged from 38% to 61%. [16][17][18] Compared with the study of symptomatic women in Uganda, Zimbabwe, and South Africa reporting an overall sensitivity of 52%, 17 the BVBlue test performed better in this study of Kenyan women (overall sensitivity, 82%; self-reported abnormal vaginal discharge sensitivity, 74%).…”
Section: Discussionmentioning
confidence: 99%